Diabetes Mellitus Type 2
Conditions
Keywords
Type 2 Diabetes, Digital Health, Continuous Glucose Monitoring
Brief summary
We will conduct a prospective, single-center observational study involving 60 adult T2D patients recruited from Chang Gung Memorial Hospital. Participants will be randomly allocated to either a CGM group or a control group receiving standard care. The intervention group will utilize mobile apps for medication tracking, and a remote communication platform. All participants will collect clinical data-including HbA1c, Time in Range (TIR), insulin use-at baseline and 12 weeks. Patient adherence and satisfaction with CGM will also be assessed.
Interventions
Use CGM in the glucose monitoring for CGM arm
Sponsors
Study design
Eligibility
Inclusion criteria
\- Patients with confirmed diagnosis of T2D for \>1 year, capable of using a smartphone, and willing to sign informed consent.
Exclusion criteria
* Patients with severe cardiac, hepatic, or renal disease; pregnant women; those participating in other experimental treatments; or unable to follow up.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HbA1c | From baseline to week 12 | Change in HbA1c |
| TIR | From baseline to week 12 | Improvement in Time in Range |
Countries
Taiwan